Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1658551 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $19.73Day +0.92%Mkt cap $2.2B1Y +148.2%Off 52W high −2.4%Vol (1Y) 60.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,362 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest11.0% of sh out |
| Days to cover9.2d |
| 13F net flow (QoQ)+2.86% |
| Top-10 13F concentration57.4% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$150.1M |
| ROE−61.6% |
| ROIC−145.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+63.3% |
| 1Y+148.2% |
| 3Y−15.9% |
| 5Y+9.2% |
| Since incept. (ann.)+2.9% |
Total return through 2026-07-29 · series begins 2017-06-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)60.5% |
| Ann. volatility (3Y)86.6% |
| Sharpe (1Y)1.81 |
| Sharpe (3Y)0.60 |
| Max drawdown (1Y)−30.6% |
| Max drawdown (3Y)−93.1% |
| Beta (3Y vs SPY)0.66 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 16.6M | $231M | 14.96% | +0.7% |
| BlackRock, Inc. | 8.8M | $123M | 7.94% | −2.5% |
| PERCEPTIVE ADVISORS LLC | 8.3M | $115M | 7.45% | +0.0% |
| TCG Crossover Management, LLC | 6.2M | $87M | 5.62% | +0.0% |
| Commodore Capital LP | 5.7M | $79M | 5.08% | +0.0% |
| JANUS HENDERSON GROUP PLC | 5.0M | $69M | 4.48% | +11.6% |
| Saturn V Capital Management LP | 4.3M | $60M | 3.91% | −3.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $58M | 3.72% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 103.3% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 14,800,969 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.37 | — | — | — |
| 2025-12-31 | 2026-03-03 | — | — | $0 | — |
| 2025-09-30 | 2025-11-06 | −$0.37 | — | $0 | −100.0% |
| 2025-06-30 | 2025-08-07 | −$0.46 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
